// App-Quantinova.ai

P942 : DREAMM-9: PHASE I STUDY OF BELANTAMAB MAFODOTIN PLUS STANDARD OF CARE IN PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA

Researchers

Presenter

  • Saad Z Usmani

Principal Investigators

  • Youngil Koh

  • Arnzazu Alonso Alonso

  • Xavier Leleu

  • Hang Quach

  • Chang-Ki Min

  • Wojciech Janowski

  • Al-Ola Abdallah

  • Mamta Garg

  • Irwindeep Sandhu

  • Enrique M Ocio San Miguel

  • Albert Oriol

  • Karthik Ramasamy

  • Katja Weisel

  • Britta Besemer

  • Michele Cavo

  • Ira V Gupta

  • Marek Hus

Medical Centers

  • Calvary Mater Newcastle, Newcastle, Australia

  • Hospital Universitario Marqués de Valdecilla. IDIVAL. Universidad de Cantabria., Cantabria, Spain

  • Seoul National University Hospital, Seoul, Korea

  • Department of Oncology, Clinica Universidad de Navarra, Pamplona, Spain

  • University of Alberta, Edmonton, AB, Canada

  • University of Tubingen, Tubingen, Germany

  • GlaxoSmithkline,Waltham, MA,Estados Unidos

  • GlaxoSmithKline,Barcelona,Espagne

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • Department of Oncology, Clinica Universidad de Navarra, Pamplona, Spain

  • CHU de Poitiers,Potiers ,Frankreich

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • University of Tubingen, Tubingen, Germany

  • GlaxoSmithKline, Upper Providence, PA, United States.

  • University Hospital Quirón Madrid,Madrid,Espagne

  • Memorial Sloan-Kettering Cancer Center, New York, NY, United States

  • Leicester Royal Infirmary Haematology, Leicester, United Kingdom

  • GlaxoSmithkline,Waltham, MA,Stati Uniti

  • Memorial Sloan-Kettering Cancer Center, New York, NY, United States

  • Churchill Hospital, Headington,Oxford,Royaume-uni

  • Leicester Royal Infirmary, Leicester, UK

  • University Hospital Quirón Madrid,Madrid,Espagne

  • University of Kansas Medical Center, Kansas City, Kansas, United States

  • St Vincents Hospital, University of Melbourne, Melbourne, Victoria, Australia

  • Churchill Hospital, Headingt

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istitutodi Ematologia 'Seràgnoli', Universitàdegli Studi di Bologna,Bolonga,Italie

  • Surgery, The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Republic of Korea

  • Department of Hematology, Clínica

  • Churchill Hospital, Headington,Oxford,Reino Unido

  • GlaxoSmithKline,Barcelona,Espagne

  • University of Tuebingen,Tuebingen,Deutschland

  • GlaxoSmithkline,Waltham, MA,États-unis

  • Department of Oncology, Clinica Universidad de Navarra, Pamplona, Spain

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Department of Hematooncology and Bone Marrow Transplantation, Medical University of Lublin,Lublin,Polonia

  • University Medical Center Utrecht,

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Calvary Mater Newcastle,Newcastle,Австралия

  • GlaxoSmithKline, Upper Providence, PA, United States.

  • University of Tuebingen,Tuebingen,Deutschland

  • Hospital Universitario Marqués de Valdecilla. IDIVAL. Universidad de Cantabria., Cantabria, Spain

  • Leicester Royal Infirmary, Leicester, UK

  • Calvary Mater Newcastle, Newcastle, Australia

  • CHU de Poitiers,Potiers ,Frankreich

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istitutodi Ematologia 'Seràgnoli', Universitàdegli Studi di Bologna,Bolonga,Italie

  • Department of Hematooncology and Bone Marrow Transplantation, Medical University of

  • Department of Hematooncology and Bone Marrow Transplantation, Medical University of Lublin,Lublin,Polonia

  • , Hospital Un

  • Churchill Hospital, Oxford, United Kingdom

  • Churchill Hospital, Headington,Oxford,Verenigd Koninkrijk

  • Catholic University of Korea Seoul St. Mary's Hospital,Seoul,Corea del Sud

  • Institut Català d'Oncologia and Institut Josep Carreras - Hospital Universitari Germans Trias i Pujol (HUGTP),Badalona,Spagna

  • Leicester Royal Infirmary,Leicester,Vereinigtes Königreich

  • GlaxoSmithKline,Barcelona,Espagne

  • Leicester Royal Infirmary,Leicester,Royaume-uni

  • University of Kansas,Kansas City, KS,États-unis

  • Seoul National University Bundang Hospital,Seongnam,Corée, République De

  • University Hospital Quirón Madrid,Madrid,Espagne

  • GlaxoSmithKline, Waltham, MA

  • GlaxoSmithKline,Barcelona,Испания

  • Internal Medicine,Seoul National University Hospital ,Seoul,South Korea，Republic

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istitutodi Ematologia 'Seràgnoli', Universitàdegli Studi di Bologna,Bolonga,Italie

  • University Hospital Quirón Madrid,Madrid,Espagne

  • CHU de Poitiers,Potiers ,Франция

  • The University of Kansas Cancer Center,Kansas City, KS,Vereinigte Staaten

  • University of Tuebingen,Tuebingen,Deutschland

  • University of Kansas, Kansas City, KS

  • Institut Català d'Oncolo

  • GlaxoSmithKline,Upper Providence, PA,Estados Unidos

  • St Vincents Hospital, University of Melbourne, Melbourne, Victoria, Australia

  • GlaxoSmithKline, Upper Providence, PA

  • Memorial Sloan Kettering Cancer Center,New York ,États-unis

  • GlaxoSmithKline,Barcelona,Espagne

  • St Vincents Hospital, University of Melbourne, Melbourne, Victoria, Australia

  • CHU Poitiers, Poitiers, France

  • CHU de Poitiers,Potiers ,Frankreich

  • Department of Hematooncology and Bone Marrow Transplantation, Medical University of Lublin,Lublin,Polonia

  • Catholic

  • GlaxoSmithKline,Upper Providence, PA,Estados Unidos

  • Calvary Mater Newcastle, Newcastle, Australia

  • Leicester Royal Infirmary,Leicester,Vereinigtes Königreich

  • Churchill Hospital, Headington,Oxford,Vereinigtes Königreich

  • University of Kansas,Kansas City, KS,États-unis

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • Memorial Sloan-Kettering Cancer Center, New York, NY, United States

  • University of Tuebingen,Tuebingen,Германия

  • Calvary Mater Newcastle, Newcastle, Australia

  • GlaxoSmithKline,Upper Providence, PA,Estados Unidos

  • University of Alberta, Edmonton, AB, Canada

  • Institut Català d'Oncologia and Institut Josep Carreras - Hospital Universitari Germans Trias i Pujol (HUGTP),Badalona,Spagna

  • St Vincents Hospital, University of Melbourne, Melbourne, Victoria, Australia

  • Catholic University of Korea Seoul St. Mary's Hospital,Seoul,Corea del Sud

  • Seoul National University Hospital,Seoul,Корея, южная

  • Catholic University of Korea Seoul St. Mary's Hospital,Seoul,South Korea，Republic

  • Universit

  • Department of Oncology, Clinica Universidad de Navarra, Pamplona, Spain

  • University Hospital Quirón Madrid,Madrid,Espagne

  • Churchill Hospital, Headington,Oxford,Reino Unido

  • Leicester Royal Infirmary, Leicester, UK

  • Seoul National University Hospital, Seoul, Korea

  • University of Tuebingen,Tuebingen,Deutschland

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • GlaxoSmithKline, Upper Providence, PA, United States.

  • Institut Català d'Oncologia and Institut Josep Carreras - Hospital Universitari Germans Trias i Pujol (HUGTP),Badalona,Spagna

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • Seoul National University Hospital, Seoul, Korea

  • CHU de Poitiers,Potiers ,Frankreich

  • University of Tuebingen,Tuebingen,Deutschland

  • St Vincents Hospital, University of Melbourne, Melbourne, Victoria, Australia

  • University of Alberta,Edmonton,Канада

  • Department of Oncology, Clinica Universidad de Navarra, Pamplona, Spain

  • Hospital Universitario Marqués de Valdecilla. IDIVAL. Universidad de Cantabria., Cantabria, Spain

  • University of Kansas,Kansas City, KS,Vereinigte Staaten

  • University Hospital Quirón Madrid,Madrid,Espagne

  • Hospital Universitario Marqués de Valdecilla. IDIVAL. Universidad de Cantabria., Cantabria, Spain

  • University Hospital Quirón Madrid,Madrid,Espagne

  • GlaxoSmithkline,Waltham, MA,Verenigde Staten

  • GlaxoSmithkline,Waltham, MA,Verenigde Staten

  • University Hospital Quirón Madrid,Madrid,Espagne

  • GlaxoSmithKline,Barcelona,Espagne

  • University of Tuebingen,Tuebingen,Deutschland

  • University of Alberta, Edmonton, AB, Canada

  • GlaxoSmithkline,Waltham, MA,United States

  • GlaxoSmithKline,Barcelona,Espagne

  • The University of Kansas Cancer Center,Kansas City, KS,Vereinigte Staaten

  • The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul

  • St. Vincent’s Hospital, Melbourne

  • GlaxoSmithKline,Barcelona,Espagne

  • CHU Poitiers, Poitiers, France

  • Calvary Mater Newcastle, Newcastle, Australia

Locations

  • United States

  • Poland

  • Turkey

  • Republic of South Korea

  • Spain

  • France

  • Australia

  • Turkmenistan

  • South Africa

  • United Kingdom

  • Canada

  • Germany

  • Venezuela

  • Republic of South Korea

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • GSK2857916

Outcome

  • N/A

Study Design

  • Randomized

  • Pharmacokinetics

  • Open Label

  • Cohort

Phase

  • I

Study Id's

  • NCT04091126

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved